| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortitis | 9 | 2023 | 74 | 4.040 |
Why?
|
| Myocardium | 28 | 2024 | 4725 | 3.030 |
Why?
|
| Amyloidosis | 11 | 2020 | 817 | 2.250 |
Why?
|
| Giant Cell Arteritis | 8 | 2024 | 306 | 2.100 |
Why?
|
| Autopsy | 14 | 2022 | 1007 | 2.030 |
Why?
|
| Temporal Arteries | 5 | 2024 | 154 | 1.680 |
Why?
|
| Myocarditis | 9 | 2024 | 787 | 1.640 |
Why?
|
| Hydrogen Peroxide | 8 | 2008 | 729 | 1.500 |
Why?
|
| Cardiomyopathies | 7 | 2024 | 1964 | 1.400 |
Why?
|
| Aorta | 8 | 2023 | 2041 | 1.350 |
Why?
|
| Tunica Intima | 5 | 2010 | 458 | 1.210 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 6 | 2013 | 16 | 1.170 |
Why?
|
| Immunoglobulin G | 12 | 2023 | 4549 | 1.120 |
Why?
|
| Diagnosis, Differential | 34 | 2021 | 12970 | 1.040 |
Why?
|
| Mesenteric Vascular Occlusion | 3 | 2014 | 92 | 1.000 |
Why?
|
| Shock, Cardiogenic | 3 | 2022 | 709 | 1.000 |
Why?
|
| Death, Sudden | 2 | 2024 | 302 | 0.970 |
Why?
|
| Mesenteric Arteries | 2 | 2014 | 178 | 0.940 |
Why?
|
| Cardiovascular System | 2 | 2022 | 835 | 0.920 |
Why?
|
| Guanine Nucleotide Exchange Factors | 10 | 2013 | 568 | 0.880 |
Why?
|
| Heart Neoplasms | 6 | 2016 | 362 | 0.880 |
Why?
|
| Coronary Aneurysm | 2 | 2018 | 232 | 0.810 |
Why?
|
| Aortic Diseases | 6 | 2023 | 735 | 0.780 |
Why?
|
| Macrophages | 7 | 2024 | 5768 | 0.750 |
Why?
|
| Pheochromocytoma | 2 | 2018 | 328 | 0.740 |
Why?
|
| Immune System Diseases | 3 | 2016 | 257 | 0.730 |
Why?
|
| Syncope | 4 | 2018 | 427 | 0.720 |
Why?
|
| Casein Kinase Ialpha | 3 | 2013 | 26 | 0.720 |
Why?
|
| Prosthesis Failure | 2 | 2020 | 1204 | 0.710 |
Why?
|
| Fatal Outcome | 13 | 2020 | 1834 | 0.690 |
Why?
|
| Exanthema | 3 | 2022 | 503 | 0.680 |
Why?
|
| Anemia, Hemolytic | 1 | 2020 | 163 | 0.670 |
Why?
|
| Hematuria | 1 | 2020 | 233 | 0.660 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2019 | 1530 | 0.630 |
Why?
|
| Lung | 17 | 2022 | 9995 | 0.620 |
Why?
|
| Coronary Vessels | 8 | 2023 | 3096 | 0.620 |
Why?
|
| beta 2-Microglobulin | 1 | 2019 | 329 | 0.610 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2012 | 2469 | 0.600 |
Why?
|
| Amyloid | 3 | 2017 | 841 | 0.590 |
Why?
|
| Pathology, Surgical | 3 | 2016 | 151 | 0.590 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2017 | 29 | 0.580 |
Why?
|
| Aneurysm, False | 2 | 2017 | 254 | 0.580 |
Why?
|
| Aorta, Thoracic | 6 | 2023 | 1096 | 0.570 |
Why?
|
| Heart Transplantation | 10 | 2019 | 3234 | 0.570 |
Why?
|
| Tongue | 2 | 2011 | 403 | 0.570 |
Why?
|
| Echocardiography | 15 | 2021 | 4991 | 0.560 |
Why?
|
| Atrial Appendage | 2 | 2021 | 283 | 0.550 |
Why?
|
| Lipomatosis | 1 | 2017 | 112 | 0.550 |
Why?
|
| Amyloid Neuropathies, Familial | 2 | 2016 | 151 | 0.550 |
Why?
|
| Humans | 167 | 2024 | 761423 | 0.550 |
Why?
|
| Iron Overload | 1 | 2019 | 239 | 0.550 |
Why?
|
| Arteritis | 2 | 2023 | 158 | 0.550 |
Why?
|
| Plasma Cells | 4 | 2015 | 599 | 0.540 |
Why?
|
| Coronary Artery Disease | 7 | 2019 | 6395 | 0.540 |
Why?
|
| Headache | 3 | 2022 | 1256 | 0.540 |
Why?
|
| Aged | 72 | 2024 | 169235 | 0.540 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2018 | 123 | 0.530 |
Why?
|
| Heart Diseases | 10 | 2022 | 2785 | 0.520 |
Why?
|
| Mammary Arteries | 2 | 2007 | 81 | 0.520 |
Why?
|
| Male | 109 | 2024 | 360736 | 0.510 |
Why?
|
| Bacterial Infections | 2 | 2015 | 1393 | 0.510 |
Why?
|
| Heart | 8 | 2024 | 4405 | 0.510 |
Why?
|
| Saphenous Vein | 1 | 2018 | 516 | 0.500 |
Why?
|
| Adrenal Glands | 1 | 2018 | 552 | 0.500 |
Why?
|
| Pulmonary Artery | 3 | 2021 | 1938 | 0.500 |
Why?
|
| Heart Septum | 1 | 2016 | 303 | 0.500 |
Why?
|
| Popliteal Artery | 1 | 2017 | 310 | 0.490 |
Why?
|
| Middle Aged | 73 | 2024 | 220826 | 0.490 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2017 | 141 | 0.490 |
Why?
|
| Endocardium | 3 | 2020 | 248 | 0.490 |
Why?
|
| Aneurysm | 1 | 2018 | 337 | 0.480 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2015 | 169 | 0.480 |
Why?
|
| Splenectomy | 1 | 2016 | 391 | 0.480 |
Why?
|
| Dyspnea | 8 | 2019 | 1347 | 0.480 |
Why?
|
| Takayasu Arteritis | 2 | 2013 | 105 | 0.470 |
Why?
|
| Extracellular Fluid | 1 | 2015 | 165 | 0.470 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2018 | 732 | 0.450 |
Why?
|
| Hyperplasia | 5 | 2013 | 1152 | 0.450 |
Why?
|
| Endovascular Procedures | 4 | 2015 | 2181 | 0.450 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 565 | 0.450 |
Why?
|
| Cytochrome b Group | 1 | 2013 | 59 | 0.450 |
Why?
|
| Whole Body Imaging | 1 | 2015 | 283 | 0.440 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 2119 | 0.430 |
Why?
|
| Mitral Valve | 2 | 2020 | 1471 | 0.430 |
Why?
|
| Autoimmune Diseases | 5 | 2012 | 2248 | 0.420 |
Why?
|
| Carotid Artery Injuries | 1 | 2013 | 96 | 0.420 |
Why?
|
| Endocarditis, Bacterial | 2 | 2014 | 443 | 0.420 |
Why?
|
| Biopsy | 9 | 2024 | 6766 | 0.420 |
Why?
|
| Carotid Artery, Common | 1 | 2013 | 175 | 0.410 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2016 | 1313 | 0.410 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2013 | 173 | 0.410 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2012 | 52 | 0.410 |
Why?
|
| Endothelium, Vascular | 6 | 2010 | 4430 | 0.410 |
Why?
|
| Vasculitis | 3 | 2023 | 521 | 0.400 |
Why?
|
| Amyloidosis, Familial | 1 | 2012 | 16 | 0.400 |
Why?
|
| Tachycardia, Ventricular | 3 | 2018 | 1304 | 0.400 |
Why?
|
| Heart Valve Prosthesis | 1 | 2020 | 1469 | 0.390 |
Why?
|
| Pulmonary Embolism | 5 | 2021 | 2566 | 0.390 |
Why?
|
| Vascular Diseases | 3 | 2022 | 1161 | 0.390 |
Why?
|
| Nervous System Diseases | 1 | 2022 | 1666 | 0.390 |
Why?
|
| Female | 85 | 2024 | 392581 | 0.390 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2013 | 1491 | 0.390 |
Why?
|
| Systemic Vasculitis | 1 | 2012 | 36 | 0.390 |
Why?
|
| Aortic Valve | 3 | 2020 | 1961 | 0.380 |
Why?
|
| Surgical Procedures, Operative | 1 | 2022 | 1923 | 0.370 |
Why?
|
| Electrocardiography | 7 | 2021 | 6384 | 0.370 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 491 | 0.360 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2011 | 42 | 0.360 |
Why?
|
| Sarcoidosis | 1 | 2016 | 521 | 0.360 |
Why?
|
| Histological Techniques | 1 | 2011 | 193 | 0.360 |
Why?
|
| Iron | 1 | 2019 | 1792 | 0.350 |
Why?
|
| Prealbumin | 1 | 2012 | 222 | 0.350 |
Why?
|
| Renal Dialysis | 2 | 2019 | 1797 | 0.350 |
Why?
|
| Diffuse Axonal Injury | 2 | 2009 | 49 | 0.340 |
Why?
|
| Coronary Artery Bypass | 3 | 2018 | 2189 | 0.340 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 15498 | 0.340 |
Why?
|
| Edema | 4 | 2016 | 767 | 0.340 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 799 | 0.340 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 4110 | 0.340 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1116 | 0.340 |
Why?
|
| Body Height | 1 | 2016 | 1570 | 0.330 |
Why?
|
| Myxoma | 2 | 2007 | 114 | 0.320 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2013 | 545 | 0.320 |
Why?
|
| Axons | 5 | 2004 | 1674 | 0.320 |
Why?
|
| Aortic Rupture | 1 | 2012 | 319 | 0.310 |
Why?
|
| Aged, 80 and over | 25 | 2021 | 58956 | 0.310 |
Why?
|
| Traumatology | 1 | 2009 | 100 | 0.310 |
Why?
|
| Immunohistochemistry | 12 | 2021 | 11073 | 0.310 |
Why?
|
| Chest Pain | 5 | 2019 | 1090 | 0.300 |
Why?
|
| Carotid Artery, Internal | 2 | 2008 | 445 | 0.300 |
Why?
|
| Atherosclerosis | 4 | 2015 | 3407 | 0.300 |
Why?
|
| Mediastinal Diseases | 1 | 2008 | 91 | 0.300 |
Why?
|
| Venous Thromboembolism | 2 | 2018 | 1866 | 0.300 |
Why?
|
| Pleural Effusion | 2 | 2015 | 342 | 0.300 |
Why?
|
| Polyvinyls | 1 | 2008 | 154 | 0.300 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2008 | 251 | 0.290 |
Why?
|
| Puerperal Disorders | 1 | 2010 | 299 | 0.290 |
Why?
|
| Calcinosis | 1 | 2016 | 1469 | 0.290 |
Why?
|
| Cell Proliferation | 9 | 2019 | 10441 | 0.290 |
Why?
|
| Pericardium | 3 | 2020 | 675 | 0.290 |
Why?
|
| Casein Kinase I | 1 | 2007 | 46 | 0.280 |
Why?
|
| Stents | 5 | 2015 | 3179 | 0.280 |
Why?
|
| Brain Injuries | 6 | 2004 | 2053 | 0.280 |
Why?
|
| Liver Transplantation | 1 | 2019 | 2333 | 0.280 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2006 | 48 | 0.280 |
Why?
|
| Embolism | 2 | 2007 | 400 | 0.270 |
Why?
|
| Dura Mater | 1 | 2008 | 290 | 0.270 |
Why?
|
| Immunosuppressive Agents | 3 | 2021 | 4172 | 0.270 |
Why?
|
| Predictive Value of Tests | 8 | 2024 | 15262 | 0.270 |
Why?
|
| Radiography | 8 | 2016 | 6966 | 0.270 |
Why?
|
| Hemosiderosis | 1 | 2007 | 66 | 0.270 |
Why?
|
| Foreign Bodies | 1 | 2011 | 402 | 0.270 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2008 | 288 | 0.270 |
Why?
|
| Heart Atria | 2 | 2011 | 1347 | 0.270 |
Why?
|
| Pulmonary Fibrosis | 1 | 2010 | 505 | 0.270 |
Why?
|
| Forensic Pathology | 2 | 2016 | 23 | 0.270 |
Why?
|
| Carotid Artery Diseases | 2 | 2014 | 877 | 0.270 |
Why?
|
| Carotid Arteries | 2 | 2014 | 941 | 0.260 |
Why?
|
| Specimen Handling | 1 | 2011 | 702 | 0.260 |
Why?
|
| Models, Organizational | 1 | 2009 | 546 | 0.260 |
Why?
|
| Papillary Muscles | 1 | 2006 | 192 | 0.260 |
Why?
|
| Behavior Therapy | 1 | 2012 | 880 | 0.260 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2012 | 1228 | 0.260 |
Why?
|
| Radiography, Thoracic | 4 | 2020 | 1302 | 0.260 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3312 | 0.250 |
Why?
|
| Phloroglucinol | 1 | 2005 | 6 | 0.250 |
Why?
|
| Biomedical Research | 1 | 2021 | 3429 | 0.250 |
Why?
|
| Myocardial Infarction | 7 | 2017 | 11458 | 0.250 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2005 | 33 | 0.250 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2006 | 151 | 0.250 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2018 | 1088 | 0.250 |
Why?
|
| Body Weight | 1 | 2016 | 4618 | 0.250 |
Why?
|
| Adult | 50 | 2024 | 221148 | 0.240 |
Why?
|
| Retinal Vasculitis | 1 | 2005 | 46 | 0.240 |
Why?
|
| Conducted Energy Weapon Injuries | 2 | 2014 | 2 | 0.240 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 1407 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2023 | 36423 | 0.240 |
Why?
|
| Immunologic Factors | 2 | 2016 | 1588 | 0.240 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2010 | 518 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2019 | 20556 | 0.240 |
Why?
|
| Ulnar Artery | 1 | 2004 | 15 | 0.230 |
Why?
|
| Cholangiocarcinoma | 2 | 2022 | 552 | 0.230 |
Why?
|
| Bile Duct Neoplasms | 2 | 2022 | 605 | 0.230 |
Why?
|
| Brain Stem | 1 | 2009 | 858 | 0.230 |
Why?
|
| Axonal Transport | 1 | 2004 | 178 | 0.230 |
Why?
|
| T-Lymphocytes | 4 | 2019 | 10194 | 0.230 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 6339 | 0.230 |
Why?
|
| Skin | 3 | 2014 | 4481 | 0.230 |
Why?
|
| Blood Chemical Analysis | 2 | 2020 | 437 | 0.230 |
Why?
|
| Lung Neoplasms | 6 | 2020 | 13337 | 0.220 |
Why?
|
| Disease Progression | 8 | 2024 | 13502 | 0.220 |
Why?
|
| Societies, Medical | 4 | 2019 | 3905 | 0.220 |
Why?
|
| Urinalysis | 2 | 2020 | 368 | 0.220 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2008 | 954 | 0.220 |
Why?
|
| Radiotherapy | 1 | 2010 | 1499 | 0.220 |
Why?
|
| Confusion | 2 | 2017 | 278 | 0.220 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 2141 | 0.220 |
Why?
|
| Head Injuries, Closed | 2 | 2003 | 133 | 0.210 |
Why?
|
| Troponin I | 3 | 2024 | 651 | 0.210 |
Why?
|
| Recurrence | 4 | 2018 | 8469 | 0.210 |
Why?
|
| Inflammation | 7 | 2024 | 10762 | 0.210 |
Why?
|
| ras Proteins | 2 | 2005 | 1053 | 0.210 |
Why?
|
| B-Lymphocytes | 7 | 2024 | 4764 | 0.210 |
Why?
|
| Fever | 5 | 2014 | 1618 | 0.210 |
Why?
|
| Myocardial Ischemia | 3 | 2014 | 2110 | 0.210 |
Why?
|
| Radiation Injuries | 1 | 2010 | 1189 | 0.210 |
Why?
|
| Radiography, Interventional | 3 | 2014 | 1121 | 0.210 |
Why?
|
| Hodgkin Disease | 1 | 2010 | 1378 | 0.210 |
Why?
|
| Organelles | 1 | 2004 | 266 | 0.210 |
Why?
|
| Serum Albumin | 2 | 2016 | 675 | 0.210 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2024 | 130 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3082 | 0.210 |
Why?
|
| Cause of Death | 2 | 2024 | 3684 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3202 | 0.200 |
Why?
|
| Chronic Disease | 8 | 2021 | 9320 | 0.200 |
Why?
|
| Endothelial Cells | 4 | 2021 | 3541 | 0.200 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2004 | 151 | 0.200 |
Why?
|
| Serum Amyloid A Protein | 2 | 2015 | 127 | 0.200 |
Why?
|
| Proteoglycans | 1 | 2005 | 803 | 0.200 |
Why?
|
| Blood | 1 | 2024 | 598 | 0.200 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 584 | 0.200 |
Why?
|
| Angioplasty, Balloon | 4 | 2014 | 588 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2005 | 1246 | 0.190 |
Why?
|
| Graft Rejection | 7 | 2015 | 4445 | 0.190 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2004 | 1111 | 0.190 |
Why?
|
| Amino Acid Sequence | 13 | 2017 | 13449 | 0.190 |
Why?
|
| Animals | 58 | 2024 | 168441 | 0.190 |
Why?
|
| Ventricular Fibrillation | 2 | 2014 | 537 | 0.190 |
Why?
|
| Prednisone | 3 | 2012 | 1562 | 0.190 |
Why?
|
| Kidney | 5 | 2021 | 7049 | 0.190 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2013 | 225 | 0.190 |
Why?
|
| Respiratory Insufficiency | 2 | 2007 | 1230 | 0.190 |
Why?
|
| Glucocorticoids | 4 | 2012 | 2161 | 0.190 |
Why?
|
| Models, Neurological | 1 | 2009 | 1767 | 0.190 |
Why?
|
| Trigeminal Ganglion | 1 | 2022 | 190 | 0.190 |
Why?
|
| Antibody Formation | 1 | 2005 | 1398 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2645 | 0.180 |
Why?
|
| Treatment Outcome | 19 | 2024 | 64651 | 0.180 |
Why?
|
| Hand Injuries | 1 | 2004 | 239 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 829 | 0.180 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1055 | 0.180 |
Why?
|
| Computers, Handheld | 2 | 2013 | 209 | 0.180 |
Why?
|
| Mutation | 11 | 2017 | 30045 | 0.180 |
Why?
|
| Caspases | 2 | 2009 | 879 | 0.180 |
Why?
|
| Ventricular Function, Left | 4 | 2020 | 3879 | 0.180 |
Why?
|
| Weight Loss | 1 | 2012 | 2683 | 0.170 |
Why?
|
| Heart Failure | 7 | 2019 | 11674 | 0.170 |
Why?
|
| Central Nervous System | 2 | 2009 | 1337 | 0.170 |
Why?
|
| In Situ Hybridization | 2 | 2021 | 1900 | 0.170 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2022 | 214 | 0.170 |
Why?
|
| Lymphocyte Activation | 7 | 2012 | 5490 | 0.170 |
Why?
|
| Heart Ventricles | 3 | 2016 | 3816 | 0.170 |
Why?
|
| Muscle Cells | 1 | 2020 | 195 | 0.170 |
Why?
|
| Heart Arrest | 3 | 2014 | 1514 | 0.170 |
Why?
|
| Flavonoids | 1 | 2003 | 445 | 0.170 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 5146 | 0.170 |
Why?
|
| Lymphocytes | 3 | 2007 | 2611 | 0.170 |
Why?
|
| Neoplasms | 4 | 2024 | 22164 | 0.170 |
Why?
|
| Ribonucleoproteins | 1 | 2002 | 372 | 0.160 |
Why?
|
| Spinal Cord Injuries | 2 | 2006 | 925 | 0.160 |
Why?
|
| Vascular Neoplasms | 1 | 2021 | 166 | 0.160 |
Why?
|
| Renal Artery Obstruction | 2 | 2014 | 219 | 0.160 |
Why?
|
| Risk Factors | 12 | 2024 | 74167 | 0.160 |
Why?
|
| Aorta, Abdominal | 2 | 2012 | 625 | 0.160 |
Why?
|
| Translocation, Genetic | 2 | 2016 | 1393 | 0.160 |
Why?
|
| Molecular Sequence Data | 11 | 2010 | 17644 | 0.160 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 1427 | 0.160 |
Why?
|
| Mice, Knockout | 16 | 2017 | 14409 | 0.160 |
Why?
|
| Vena Cava, Inferior | 1 | 2001 | 459 | 0.160 |
Why?
|
| RNA, Viral | 3 | 2022 | 2846 | 0.150 |
Why?
|
| Marmota | 1 | 2017 | 12 | 0.150 |
Why?
|
| Paraproteinemias | 2 | 2012 | 248 | 0.150 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 282 | 0.150 |
Why?
|
| Repressor Proteins | 4 | 2005 | 2985 | 0.150 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 2192 | 0.150 |
Why?
|
| Subclavian Artery | 2 | 2015 | 134 | 0.150 |
Why?
|
| Camptothecin | 1 | 2021 | 590 | 0.150 |
Why?
|
| Liver | 4 | 2021 | 7532 | 0.150 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 1580 | 0.150 |
Why?
|
| Phosphorylation | 7 | 2009 | 8320 | 0.150 |
Why?
|
| Transferrin | 1 | 2019 | 284 | 0.150 |
Why?
|
| Giant Cells | 1 | 2018 | 188 | 0.150 |
Why?
|
| Polypharmacy | 1 | 2020 | 305 | 0.150 |
Why?
|
| Muscle Weakness | 1 | 2020 | 412 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2022 | 1815 | 0.150 |
Why?
|
| Embolization, Therapeutic | 2 | 2017 | 1418 | 0.150 |
Why?
|
| Lung Diseases | 2 | 2008 | 1909 | 0.150 |
Why?
|
| Hypothermia, Induced | 1 | 2003 | 756 | 0.150 |
Why?
|
| Enbucrilate | 1 | 2017 | 30 | 0.140 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2017 | 61 | 0.140 |
Why?
|
| Ureteral Diseases | 1 | 2017 | 63 | 0.140 |
Why?
|
| Endarterectomy | 1 | 2018 | 196 | 0.140 |
Why?
|
| Prosthesis Design | 3 | 2017 | 2115 | 0.140 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 269 | 0.140 |
Why?
|
| Ventricular Dysfunction | 1 | 2018 | 144 | 0.140 |
Why?
|
| Coronary Angiography | 4 | 2018 | 4472 | 0.140 |
Why?
|
| Mice | 34 | 2024 | 81509 | 0.140 |
Why?
|
| Hematologic Diseases | 1 | 2021 | 496 | 0.140 |
Why?
|
| Elastic Tissue | 2 | 2015 | 65 | 0.140 |
Why?
|
| Terminology as Topic | 2 | 2016 | 1535 | 0.140 |
Why?
|
| Interferons | 1 | 2020 | 705 | 0.140 |
Why?
|
| Postural Balance | 1 | 2021 | 621 | 0.140 |
Why?
|
| Zinc Fingers | 4 | 2005 | 579 | 0.140 |
Why?
|
| Cells, Cultured | 7 | 2013 | 18964 | 0.140 |
Why?
|
| Pyridines | 2 | 2013 | 2875 | 0.140 |
Why?
|
| Neuregulin-1 | 2 | 2009 | 135 | 0.140 |
Why?
|
| Imidazoles | 1 | 2003 | 1180 | 0.140 |
Why?
|
| Sepsis | 1 | 2011 | 2585 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 445 | 0.140 |
Why?
|
| Critical Care | 1 | 2009 | 2697 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 350 | 0.140 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2016 | 45 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 7389 | 0.130 |
Why?
|
| DNA-Binding Proteins | 6 | 2004 | 9606 | 0.130 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 125 | 0.130 |
Why?
|
| Epistaxis | 1 | 2017 | 112 | 0.130 |
Why?
|
| Stroke Volume | 3 | 2020 | 5497 | 0.130 |
Why?
|
| Postmortem Changes | 1 | 2016 | 119 | 0.130 |
Why?
|
| Cell Division | 3 | 2003 | 4466 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2009 | 8179 | 0.130 |
Why?
|
| Pathology, Clinical | 2 | 2010 | 376 | 0.130 |
Why?
|
| Fatigue | 2 | 2018 | 1551 | 0.130 |
Why?
|
| Angiotensin II | 3 | 2010 | 848 | 0.130 |
Why?
|
| Ferritins | 1 | 2019 | 597 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 561 | 0.130 |
Why?
|
| Retrospective Studies | 13 | 2021 | 80582 | 0.130 |
Why?
|
| Radiopharmaceuticals | 2 | 2016 | 2651 | 0.130 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2016 | 286 | 0.120 |
Why?
|
| Hypotension, Orthostatic | 1 | 2018 | 258 | 0.120 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 898 | 0.120 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 82 | 0.120 |
Why?
|
| Arthralgia | 2 | 2010 | 461 | 0.120 |
Why?
|
| Subcutaneous Tissue | 1 | 2015 | 132 | 0.120 |
Why?
|
| Bone Marrow | 3 | 2021 | 2910 | 0.120 |
Why?
|
| Cardiomegaly | 2 | 2010 | 591 | 0.120 |
Why?
|
| Peroxidases | 2 | 2006 | 134 | 0.120 |
Why?
|
| Autoimmunity | 4 | 2013 | 1355 | 0.120 |
Why?
|
| Guanylate Cyclase | 1 | 1995 | 205 | 0.120 |
Why?
|
| Baltimore | 1 | 2015 | 231 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2006 | 3110 | 0.120 |
Why?
|
| Polyvinyl Alcohol | 1 | 2015 | 73 | 0.120 |
Why?
|
| Lymphatic Diseases | 1 | 2016 | 320 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2002 | 1344 | 0.120 |
Why?
|
| Peritoneum | 1 | 2015 | 225 | 0.120 |
Why?
|
| Rats | 12 | 2009 | 23742 | 0.120 |
Why?
|
| Splanchnic Circulation | 1 | 2014 | 119 | 0.120 |
Why?
|
| Vena Cava Filters | 1 | 2017 | 261 | 0.120 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2014 | 19 | 0.120 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2014 | 55 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2024 | 1784 | 0.120 |
Why?
|
| Hypertrophy | 2 | 2014 | 559 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 5 | 2005 | 3792 | 0.120 |
Why?
|
| Pleura | 1 | 2015 | 244 | 0.110 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 891 | 0.110 |
Why?
|
| Lymphocyte Count | 2 | 2016 | 778 | 0.110 |
Why?
|
| RNA, Messenger | 6 | 2015 | 12796 | 0.110 |
Why?
|
| Reproducibility of Results | 8 | 2021 | 20093 | 0.110 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2013 | 44 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 17 | 2024 | 22163 | 0.110 |
Why?
|
| Bilirubin | 1 | 2015 | 436 | 0.110 |
Why?
|
| Foramen Ovale, Patent | 1 | 2016 | 208 | 0.110 |
Why?
|
| Ascites | 1 | 2015 | 338 | 0.110 |
Why?
|
| Immunoconjugates | 1 | 2021 | 954 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 1115 | 0.110 |
Why?
|
| Heme | 1 | 1995 | 313 | 0.110 |
Why?
|
| Case-Control Studies | 6 | 2024 | 22168 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 529 | 0.110 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2005 | 283 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2012 | 347 | 0.110 |
Why?
|
| Diverticulum | 1 | 2014 | 137 | 0.110 |
Why?
|
| Flow Cytometry | 5 | 2017 | 5868 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 151 | 0.110 |
Why?
|
| Nuclear Medicine | 1 | 2016 | 237 | 0.110 |
Why?
|
| Leg | 2 | 2016 | 1089 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 5305 | 0.110 |
Why?
|
| Cryptorchidism | 1 | 2014 | 151 | 0.110 |
Why?
|
| Muscular Diseases | 2 | 2008 | 553 | 0.110 |
Why?
|
| Neointima | 1 | 2013 | 133 | 0.100 |
Why?
|
| Blast Injuries | 1 | 2016 | 322 | 0.100 |
Why?
|
| Smad4 Protein | 1 | 2014 | 191 | 0.100 |
Why?
|
| Hand Deformities, Congenital | 1 | 2014 | 174 | 0.100 |
Why?
|
| Pyrimidines | 3 | 2022 | 3027 | 0.100 |
Why?
|
| Stomach | 1 | 2017 | 696 | 0.100 |
Why?
|
| Antigens, CD | 2 | 2019 | 4001 | 0.100 |
Why?
|
| Signal Transduction | 12 | 2016 | 23441 | 0.100 |
Why?
|
| Donor Selection | 1 | 2014 | 232 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2005 | 2748 | 0.100 |
Why?
|
| Adhesives | 1 | 2012 | 65 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1458 | 0.100 |
Why?
|
| Teleradiology | 1 | 2012 | 53 | 0.100 |
Why?
|
| Apolipoproteins B | 1 | 2014 | 386 | 0.100 |
Why?
|
| Military Personnel | 1 | 2021 | 1246 | 0.100 |
Why?
|
| Troponin T | 2 | 2024 | 779 | 0.100 |
Why?
|
| Aneurysm, Infected | 1 | 2012 | 81 | 0.100 |
Why?
|
| Aldosterone | 2 | 2010 | 870 | 0.100 |
Why?
|
| Up-Regulation | 4 | 2009 | 4124 | 0.100 |
Why?
|
| Cardiology | 2 | 2016 | 1667 | 0.100 |
Why?
|
| New Mexico | 1 | 2012 | 83 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2024 | 2549 | 0.100 |
Why?
|
| Coronary Stenosis | 2 | 2010 | 794 | 0.100 |
Why?
|
| Prognosis | 4 | 2019 | 29620 | 0.100 |
Why?
|
| Acute Disease | 4 | 2016 | 7238 | 0.100 |
Why?
|
| Syndrome | 1 | 2018 | 3268 | 0.100 |
Why?
|
| Europe | 3 | 2019 | 3423 | 0.100 |
Why?
|
| Brain Infarction | 1 | 2013 | 290 | 0.100 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2014 | 343 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8999 | 0.090 |
Why?
|
| Disease Models, Animal | 8 | 2022 | 18247 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2010 | 153 | 0.090 |
Why?
|
| E2F3 Transcription Factor | 2 | 2008 | 36 | 0.090 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2010 | 260 | 0.090 |
Why?
|
| Cadaver | 1 | 2015 | 1358 | 0.090 |
Why?
|
| Aortic Aneurysm | 2 | 2021 | 648 | 0.090 |
Why?
|
| Streptococcus anginosus | 1 | 2011 | 24 | 0.090 |
Why?
|
| Myeloid Cells | 3 | 2017 | 823 | 0.090 |
Why?
|
| Radiology Information Systems | 2 | 2013 | 529 | 0.090 |
Why?
|
| Isoxazoles | 1 | 2013 | 231 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2012 | 177 | 0.090 |
Why?
|
| Angiography | 2 | 2014 | 1599 | 0.090 |
Why?
|
| Bronchography | 1 | 2011 | 75 | 0.090 |
Why?
|
| Fusobacterium | 1 | 2011 | 53 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2004 | 2188 | 0.090 |
Why?
|
| Organ Size | 1 | 2016 | 2254 | 0.090 |
Why?
|
| Thoracic Arteries | 1 | 2010 | 40 | 0.090 |
Why?
|
| Pneumonia | 1 | 2022 | 2140 | 0.090 |
Why?
|
| Kinetics | 5 | 2005 | 6374 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2015 | 696 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2014 | 748 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2015 | 5036 | 0.090 |
Why?
|
| Brain Abscess | 1 | 2011 | 120 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2015 | 1404 | 0.090 |
Why?
|
| Hardness | 1 | 2009 | 35 | 0.090 |
Why?
|
| Joint Diseases | 1 | 2014 | 459 | 0.080 |
Why?
|
| Hematoma | 2 | 2005 | 768 | 0.080 |
Why?
|
| Renal Insufficiency | 2 | 2014 | 809 | 0.080 |
Why?
|
| Comorbidity | 3 | 2020 | 10498 | 0.080 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2009 | 71 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 704 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 694 | 0.080 |
Why?
|
| Tongue Diseases | 1 | 2010 | 68 | 0.080 |
Why?
|
| Purines | 2 | 2019 | 605 | 0.080 |
Why?
|
| Sarcoma | 1 | 2021 | 1801 | 0.080 |
Why?
|
| Leukocytes | 1 | 2017 | 2028 | 0.080 |
Why?
|
| Abdominal Pain | 2 | 2012 | 1071 | 0.080 |
Why?
|
| Carotid Stenosis | 2 | 2007 | 860 | 0.080 |
Why?
|
| Migraine Disorders | 1 | 2022 | 1700 | 0.080 |
Why?
|
| Telepathology | 1 | 2009 | 77 | 0.080 |
Why?
|
| Syndecan-1 | 1 | 2010 | 163 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2020 | 1521 | 0.080 |
Why?
|
| Oral Ulcer | 1 | 2010 | 96 | 0.080 |
Why?
|
| Pulmonary Alveoli | 2 | 2022 | 650 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4575 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2012 | 534 | 0.080 |
Why?
|
| Ultrasonography | 4 | 2014 | 5970 | 0.080 |
Why?
|
| Polyuria | 1 | 2008 | 37 | 0.080 |
Why?
|
| Bronchiectasis | 1 | 2010 | 139 | 0.080 |
Why?
|
| Temperature | 2 | 2008 | 2228 | 0.080 |
Why?
|
| False Negative Reactions | 1 | 2010 | 573 | 0.080 |
Why?
|
| Behcet Syndrome | 1 | 2009 | 86 | 0.080 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2015 | 696 | 0.080 |
Why?
|
| Growth Disorders | 1 | 2014 | 653 | 0.080 |
Why?
|
| Viscosity | 1 | 2009 | 336 | 0.080 |
Why?
|
| Jaundice | 1 | 2009 | 94 | 0.080 |
Why?
|
| Amyloid beta-Peptides | 1 | 2002 | 3837 | 0.080 |
Why?
|
| Stress, Psychological | 2 | 2014 | 4477 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1624 | 0.080 |
Why?
|
| Aneurysm, Ruptured | 1 | 2014 | 463 | 0.080 |
Why?
|
| Neutrophils | 4 | 2017 | 3766 | 0.080 |
Why?
|
| Elastic Modulus | 1 | 2009 | 211 | 0.080 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2009 | 148 | 0.080 |
Why?
|
| Monocytes | 3 | 2017 | 2572 | 0.080 |
Why?
|
| Necrosis | 2 | 2011 | 1608 | 0.080 |
Why?
|
| Defibrillators, Implantable | 1 | 2018 | 1490 | 0.080 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2007 | 24 | 0.080 |
Why?
|
| Caveolin 1 | 1 | 2010 | 256 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2011 | 322 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3874 | 0.080 |
Why?
|
| Brain | 7 | 2019 | 27107 | 0.070 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2007 | 51 | 0.070 |
Why?
|
| Catheterization | 1 | 2013 | 1432 | 0.070 |
Why?
|
| Phorbol Esters | 2 | 2007 | 108 | 0.070 |
Why?
|
| Shock | 1 | 2010 | 314 | 0.070 |
Why?
|
| Genes, ras | 2 | 2009 | 654 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2016 | 3466 | 0.070 |
Why?
|
| Fibroblasts | 3 | 2024 | 4140 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2019 | 1404 | 0.070 |
Why?
|
| Protein Splicing | 1 | 2007 | 16 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 1037 | 0.070 |
Why?
|
| Chimera | 1 | 2009 | 453 | 0.070 |
Why?
|
| Solvents | 1 | 2008 | 294 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8529 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2013 | 908 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2005 | 1750 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2024 | 6532 | 0.070 |
Why?
|
| Tinnitus | 1 | 2010 | 196 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2007 | 95 | 0.070 |
Why?
|
| Pulmonary Edema | 2 | 2007 | 409 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1287 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2014 | 815 | 0.070 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 1266 | 0.070 |
Why?
|
| Binding Sites | 4 | 2014 | 6055 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2013 | 1595 | 0.070 |
Why?
|
| Coronary Thrombosis | 1 | 2010 | 440 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 237 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2012 | 1113 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2008 | 277 | 0.070 |
Why?
|
| Time | 1 | 2008 | 545 | 0.070 |
Why?
|
| Bronchi | 1 | 2011 | 845 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2008 | 282 | 0.070 |
Why?
|
| Embolectomy | 1 | 2007 | 129 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 944 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2012 | 11526 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 1995 | 2133 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2019 | 3614 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2014 | 1201 | 0.070 |
Why?
|
| Multiple Organ Failure | 1 | 2009 | 387 | 0.070 |
Why?
|
| Vocal Cord Paralysis | 1 | 2010 | 272 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 3163 | 0.070 |
Why?
|
| Optic Neuritis | 1 | 2008 | 174 | 0.070 |
Why?
|
| Paresis | 1 | 2007 | 176 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1835 | 0.070 |
Why?
|
| Jogging | 1 | 2005 | 18 | 0.070 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 961 | 0.070 |
Why?
|
| Hypesthesia | 1 | 2006 | 107 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1179 | 0.060 |
Why?
|
| Ischemia | 1 | 2014 | 1877 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2013 | 4510 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2007 | 2908 | 0.060 |
Why?
|
| Iliac Artery | 1 | 2007 | 343 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2022 | 1555 | 0.060 |
Why?
|
| Blindness | 1 | 2010 | 584 | 0.060 |
Why?
|
| Chemokines | 5 | 2017 | 959 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 672 | 0.060 |
Why?
|
| Surface Properties | 1 | 2008 | 1160 | 0.060 |
Why?
|
| Sotalol | 1 | 2005 | 47 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 1458 | 0.060 |
Why?
|
| Apoptosis | 6 | 2019 | 9488 | 0.060 |
Why?
|
| Appendicitis | 1 | 2012 | 675 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3418 | 0.060 |
Why?
|
| Transfection | 1 | 2013 | 5775 | 0.060 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2005 | 158 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6132 | 0.060 |
Why?
|
| Aggrecans | 1 | 2005 | 89 | 0.060 |
Why?
|
| Pilonidal Sinus | 1 | 2005 | 16 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2015 | 15650 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2021 | 4813 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1706 | 0.060 |
Why?
|
| Metoprolol | 1 | 2005 | 90 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2012 | 10766 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2012 | 1947 | 0.060 |
Why?
|
| Proteinuria | 2 | 2005 | 607 | 0.060 |
Why?
|
| Materials Testing | 1 | 2008 | 863 | 0.060 |
Why?
|
| Intermittent Claudication | 1 | 2007 | 304 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 5665 | 0.060 |
Why?
|
| Pulmonary Veins | 1 | 2011 | 746 | 0.060 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2006 | 140 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2009 | 609 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 4248 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2298 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2005 | 296 | 0.060 |
Why?
|
| RNA Interference | 1 | 2013 | 2831 | 0.060 |
Why?
|
| Paraganglioma | 1 | 2006 | 142 | 0.060 |
Why?
|
| Ventricular Myosins | 1 | 2024 | 65 | 0.060 |
Why?
|
| Exercise Test | 1 | 2012 | 2129 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2012 | 928 | 0.060 |
Why?
|
| Multigene Family | 1 | 2008 | 1077 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2007 | 599 | 0.060 |
Why?
|
| Thrombophlebitis | 1 | 2005 | 289 | 0.060 |
Why?
|
| Purpura | 1 | 2005 | 117 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2009 | 803 | 0.060 |
Why?
|
| Plants | 1 | 2006 | 327 | 0.060 |
Why?
|
| Contrast Media | 5 | 2020 | 5311 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2013 | 2300 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 191 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2006 | 384 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2018 | 8487 | 0.060 |
Why?
|
| Pharyngitis | 1 | 2006 | 219 | 0.060 |
Why?
|
| Antigens | 1 | 2009 | 1446 | 0.060 |
Why?
|
| Hypotension | 2 | 2007 | 879 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 1806 | 0.060 |
Why?
|
| Dimerization | 2 | 2005 | 891 | 0.060 |
Why?
|
| Membrane Proteins | 5 | 2013 | 7856 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 2423 | 0.060 |
Why?
|
| Bacteremia | 1 | 2011 | 978 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 39117 | 0.060 |
Why?
|
| Time Factors | 4 | 2021 | 39975 | 0.060 |
Why?
|
| Kidney Diseases | 3 | 2013 | 2092 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1494 | 0.060 |
Why?
|
| Nausea | 1 | 2006 | 679 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 1675 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2002 | 2488 | 0.050 |
Why?
|
| Models, Animal | 3 | 2008 | 2113 | 0.050 |
Why?
|
| Unconsciousness | 1 | 2005 | 250 | 0.050 |
Why?
|
| Plasma Exchange | 1 | 2024 | 158 | 0.050 |
Why?
|
| Cyclooxygenase 1 | 1 | 2003 | 97 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2012 | 1613 | 0.050 |
Why?
|
| Diacylglycerol Kinase | 1 | 2003 | 46 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1970 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2009 | 991 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2012 | 2494 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 840 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2007 | 560 | 0.050 |
Why?
|
| Prospective Studies | 6 | 2023 | 54415 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3356 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2004 | 12125 | 0.050 |
Why?
|
| Adolescent | 9 | 2022 | 88313 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2005 | 502 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2013 | 2007 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 685 | 0.050 |
Why?
|
| Running | 1 | 2007 | 488 | 0.050 |
Why?
|
| Dextrans | 1 | 2004 | 574 | 0.050 |
Why?
|
| Cytokines | 7 | 2016 | 7392 | 0.050 |
Why?
|
| Permeability | 1 | 2004 | 722 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 1540 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2009 | 2224 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2021 | 1967 | 0.050 |
Why?
|
| Sulfhydryl Compounds | 1 | 2004 | 298 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 878 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 211 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2003 | 271 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 318 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2024 | 513 | 0.050 |
Why?
|
| Spleen | 3 | 2013 | 2295 | 0.050 |
Why?
|
| Young Adult | 7 | 2022 | 59207 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2003 | 1647 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11740 | 0.050 |
Why?
|
| Boston | 1 | 2015 | 9330 | 0.050 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2001 | 57 | 0.050 |
Why?
|
| Chromatography | 1 | 2001 | 189 | 0.050 |
Why?
|
| Cell Survival | 3 | 2008 | 5790 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2009 | 868 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2006 | 1150 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2002 | 69 | 0.050 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2008 | 1208 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2021 | 41446 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 15838 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2012 | 2690 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 457 | 0.050 |
Why?
|
| Risk Assessment | 5 | 2014 | 23990 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 427 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2003 | 1688 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 266 | 0.050 |
Why?
|
| Intestines | 1 | 2011 | 1909 | 0.050 |
Why?
|
| Viral Load | 2 | 2021 | 3330 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4320 | 0.050 |
Why?
|
| Protein Denaturation | 1 | 2001 | 242 | 0.050 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2449 | 0.050 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2003 | 267 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2001 | 344 | 0.050 |
Why?
|
| Capsid Proteins | 1 | 2005 | 468 | 0.050 |
Why?
|
| Umbilical Veins | 1 | 2002 | 426 | 0.050 |
Why?
|
| Estradiol | 1 | 2008 | 1937 | 0.050 |
Why?
|
| Proteomics | 2 | 2024 | 3845 | 0.050 |
Why?
|
| Mice, Transgenic | 6 | 2017 | 9535 | 0.050 |
Why?
|
| Trypsin | 1 | 2002 | 496 | 0.050 |
Why?
|
| Placenta | 1 | 2010 | 1708 | 0.050 |
Why?
|
| K562 Cells | 1 | 2003 | 642 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2005 | 773 | 0.050 |
Why?
|
| Explosions | 1 | 2021 | 108 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 1746 | 0.050 |
Why?
|
| Lymphoma | 1 | 2010 | 1901 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 830 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 1265 | 0.050 |
Why?
|
| Autoantibodies | 2 | 2024 | 2124 | 0.050 |
Why?
|
| Hand | 1 | 2006 | 902 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 916 | 0.050 |
Why?
|
| DNA | 2 | 2014 | 7219 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 6 | 2010 | 6215 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 597 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2003 | 421 | 0.050 |
Why?
|
| Chickens | 1 | 2003 | 859 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2022 | 296 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9756 | 0.050 |
Why?
|
| Vitamin A | 1 | 2003 | 613 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 2002 | 532 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2024 | 2555 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2016 | 6626 | 0.040 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2003 | 410 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 149 | 0.040 |
Why?
|
| Autoantigens | 1 | 2024 | 892 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2003 | 778 | 0.040 |
Why?
|
| Emergency Medicine | 1 | 2009 | 1197 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8641 | 0.040 |
Why?
|
| CHO Cells | 1 | 2003 | 1388 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 506 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2001 | 595 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2002 | 1060 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4434 | 0.040 |
Why?
|
| Life Style | 1 | 2012 | 3914 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2005 | 851 | 0.040 |
Why?
|
| Shock, Septic | 1 | 2006 | 768 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2002 | 731 | 0.040 |
Why?
|
| Ethanol | 1 | 2006 | 1324 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2003 | 5115 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2021 | 248 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 687 | 0.040 |
Why?
|
| Mitochondrial Diseases | 1 | 2003 | 343 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2010 | 2163 | 0.040 |
Why?
|
| Microscopy | 1 | 2024 | 903 | 0.040 |
Why?
|
| Phagocytes | 1 | 2021 | 296 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 584 | 0.040 |
Why?
|
| Cricetinae | 1 | 2003 | 2425 | 0.040 |
Why?
|
| Cysteine | 1 | 2004 | 892 | 0.040 |
Why?
|
| Receptors, Chemokine | 4 | 2003 | 652 | 0.040 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 1176 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2014 | 4793 | 0.040 |
Why?
|
| Peroxidase | 2 | 2014 | 609 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2021 | 3667 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2010 | 3530 | 0.040 |
Why?
|
| Drug Hypersensitivity | 1 | 2007 | 917 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 1229 | 0.040 |
Why?
|
| RNA | 2 | 2007 | 2723 | 0.040 |
Why?
|
| Pedigree | 1 | 2006 | 4589 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 4579 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2005 | 1793 | 0.040 |
Why?
|
| Hypertension | 3 | 2007 | 8542 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 21012 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2012 | 801 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2006 | 1808 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 2498 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3447 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.040 |
Why?
|
| Wound Healing | 1 | 2009 | 2803 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2021 | 532 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5776 | 0.040 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2006 | 916 | 0.040 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2017 | 22 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2001 | 674 | 0.040 |
Why?
|
| Protein Folding | 1 | 2001 | 870 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2005 | 1088 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 1923 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 649 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 732 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5302 | 0.040 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2004 | 1731 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 2374 | 0.040 |
Why?
|
| Mucins | 1 | 2020 | 568 | 0.040 |
Why?
|
| Transcription Factor TFIIIA | 1 | 2016 | 24 | 0.040 |
Why?
|
| Anemia | 1 | 2007 | 1508 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2001 | 1444 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 1863 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 14664 | 0.040 |
Why?
|
| Colon | 1 | 2005 | 1792 | 0.040 |
Why?
|
| Graft Survival | 3 | 2002 | 3819 | 0.030 |
Why?
|
| Pericardial Effusion | 2 | 2010 | 247 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3597 | 0.030 |
Why?
|
| Infant | 2 | 2022 | 36205 | 0.030 |
Why?
|
| Receptors, Estrogen | 2 | 2019 | 2208 | 0.030 |
Why?
|
| Apolipoproteins E | 2 | 2012 | 1443 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 2 | 2010 | 248 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2003 | 3093 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2013 | 3969 | 0.030 |
Why?
|
| Indoles | 1 | 2005 | 1832 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1405 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 1903 | 0.030 |
Why?
|
| Plasmids | 1 | 2001 | 2269 | 0.030 |
Why?
|
| Antibodies | 1 | 2004 | 2421 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2016 | 106 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2003 | 807 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1887 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 335 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 2016 | 87 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 1808 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2006 | 4370 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 4575 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2022 | 832 | 0.030 |
Why?
|
| Point Mutation | 1 | 2021 | 1596 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17912 | 0.030 |
Why?
|
| Exercise | 1 | 2012 | 5884 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 3734 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2009 | 6238 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2016 | 383 | 0.030 |
Why?
|
| Virginia | 1 | 2015 | 116 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2019 | 573 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2013 | 1135 | 0.030 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2008 | 1871 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 1995 | 310 | 0.030 |
Why?
|
| Retroperitoneal Space | 1 | 2016 | 170 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 783 | 0.030 |
Why?
|
| Protein Binding | 2 | 2005 | 9352 | 0.030 |
Why?
|
| Tunica Media | 1 | 2015 | 112 | 0.030 |
Why?
|
| Feces | 1 | 2022 | 1497 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 279 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2009 | 1847 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 1600 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 1355 | 0.030 |
Why?
|
| Gadolinium | 1 | 2020 | 960 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2022 | 42254 | 0.030 |
Why?
|
| Nasal Septum | 1 | 2016 | 130 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2007 | 3425 | 0.030 |
Why?
|
| Neurons | 3 | 2022 | 9462 | 0.030 |
Why?
|
| Immunity | 1 | 2020 | 997 | 0.030 |
Why?
|
| Movement | 1 | 2021 | 1478 | 0.030 |
Why?
|
| Bundle-Branch Block | 1 | 2016 | 278 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2014 | 1432 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2016 | 356 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2005 | 4218 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2001 | 1725 | 0.030 |
Why?
|
| Reference Values | 1 | 2021 | 4921 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 527 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 302 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13637 | 0.030 |
Why?
|
| Base Sequence | 3 | 2017 | 12450 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2014 | 198 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 4021 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2001 | 3589 | 0.030 |
Why?
|
| Rheumatology | 1 | 2019 | 615 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1994 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 2116 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2024 | 2746 | 0.030 |
Why?
|
| Heterozygote | 2 | 2014 | 2803 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2012 | 52 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2020 | 1050 | 0.030 |
Why?
|
| Facies | 1 | 2014 | 222 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2013 | 123 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2003 | 1216 | 0.030 |
Why?
|
| Piperazines | 1 | 2003 | 2523 | 0.030 |
Why?
|
| Catechols | 1 | 2012 | 62 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2005 | 1922 | 0.030 |
Why?
|
| Vertebral Artery | 1 | 2014 | 185 | 0.030 |
Why?
|
| Protein Transport | 3 | 2003 | 1966 | 0.030 |
Why?
|
| Renal Artery | 1 | 2014 | 351 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2012 | 99 | 0.030 |
Why?
|
| Logistic Models | 1 | 2007 | 13255 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2005 | 613 | 0.030 |
Why?
|
| Back Pain | 1 | 2016 | 545 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 2020 | 0.030 |
Why?
|
| Iohexol | 1 | 2013 | 204 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 1440 | 0.020 |
Why?
|
| Regeneration | 1 | 2021 | 1511 | 0.020 |
Why?
|
| Oxygen | 1 | 2003 | 4228 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 12688 | 0.020 |
Why?
|
| Skin Neoplasms | 2 | 2009 | 5819 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2008 | 3812 | 0.020 |
Why?
|
| Peptides | 1 | 2004 | 4345 | 0.020 |
Why?
|
| Injections | 1 | 2015 | 830 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2448 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2016 | 583 | 0.020 |
Why?
|
| Limb Salvage | 1 | 2014 | 481 | 0.020 |
Why?
|
| Gels | 1 | 2012 | 422 | 0.020 |
Why?
|
| I-kappa B Proteins | 2 | 2002 | 211 | 0.020 |
Why?
|
| Appendix | 1 | 2012 | 109 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8545 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2179 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3602 | 0.020 |
Why?
|
| Pregnancy | 2 | 2010 | 29862 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 1035 | 0.020 |
Why?
|
| Abdominal Abscess | 1 | 2012 | 153 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 1091 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 2016 | 685 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3244 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2009 | 2677 | 0.020 |
Why?
|
| Pain | 1 | 2006 | 5071 | 0.020 |
Why?
|
| Germinal Center | 1 | 2013 | 380 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26112 | 0.020 |
Why?
|
| Smoking | 1 | 2007 | 9052 | 0.020 |
Why?
|
| Age Factors | 1 | 2007 | 18400 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1090 | 0.020 |
Why?
|
| Prescriptions | 1 | 2012 | 386 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 4936 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 589 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2826 | 0.020 |
Why?
|
| Cattle | 1 | 1995 | 3848 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 3769 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3122 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6231 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2017 | 10089 | 0.020 |
Why?
|
| Sex Factors | 1 | 2004 | 10548 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12720 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 9469 | 0.020 |
Why?
|
| Posture | 1 | 2014 | 956 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2011 | 280 | 0.020 |
Why?
|
| Isoantigens | 2 | 2001 | 552 | 0.020 |
Why?
|
| Thrombin | 1 | 1991 | 590 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 1495 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2281 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1243 | 0.020 |
Why?
|
| Conscious Sedation | 1 | 2013 | 532 | 0.020 |
Why?
|
| Cell Line | 1 | 2003 | 15605 | 0.020 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2010 | 163 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2009 | 780 | 0.020 |
Why?
|
| Pathology, Molecular | 1 | 2011 | 328 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 527 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2880 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2008 | 114 | 0.020 |
Why?
|
| United States | 2 | 2019 | 72339 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 2 | 2007 | 1486 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2871 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2007 | 50 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 680 | 0.020 |
Why?
|
| Prevalence | 2 | 2015 | 15717 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2007 | 110 | 0.020 |
Why?
|
| Atherectomy | 1 | 2007 | 41 | 0.020 |
Why?
|
| Arteries | 1 | 2012 | 1124 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3076 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2008 | 225 | 0.020 |
Why?
|
| Fear | 1 | 2016 | 1476 | 0.020 |
Why?
|
| Neoplasms, Experimental | 2 | 2003 | 1230 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2009 | 686 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1674 | 0.020 |
Why?
|
| Violence | 1 | 2014 | 937 | 0.020 |
Why?
|
| Phenotype | 3 | 2017 | 16606 | 0.020 |
Why?
|
| HIV-1 | 1 | 2005 | 6860 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2007 | 55 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2009 | 389 | 0.020 |
Why?
|
| Molecular Probes | 1 | 2009 | 310 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2001 | 5919 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 3612 | 0.020 |
Why?
|
| Karyotyping | 1 | 2009 | 1171 | 0.020 |
Why?
|
| Receptor, erbB-2 | 2 | 2009 | 2557 | 0.020 |
Why?
|
| Family | 1 | 2017 | 3197 | 0.020 |
Why?
|
| Esterification | 1 | 2006 | 39 | 0.020 |
Why?
|
| Superoxides | 1 | 2007 | 386 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 629 | 0.020 |
Why?
|
| Motor Activity | 1 | 2016 | 2711 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2005 | 5127 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2002 | 981 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1596 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 614 | 0.020 |
Why?
|
| Transgenes | 1 | 2009 | 1010 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1276 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2012 | 911 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2014 | 1033 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2007 | 4168 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2007 | 454 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 519 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 678 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2010 | 876 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2013 | 992 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5820 | 0.020 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2006 | 128 | 0.020 |
Why?
|
| Endocarditis | 1 | 2009 | 350 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1403 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2008 | 492 | 0.020 |
Why?
|
| Child | 3 | 2022 | 80162 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2008 | 741 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2009 | 1006 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2011 | 2201 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16979 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2014 | 2331 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2811 | 0.010 |
Why?
|
| Alloys | 1 | 2005 | 110 | 0.010 |
Why?
|
| Virus Assembly | 1 | 2005 | 139 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9418 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3490 | 0.010 |
Why?
|
| Polyurethanes | 1 | 2005 | 108 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2007 | 823 | 0.010 |
Why?
|
| Keratin-10 | 1 | 2003 | 8 | 0.010 |
Why?
|
| Filtration | 1 | 2005 | 228 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2605 | 0.010 |
Why?
|
| Canada | 1 | 2009 | 2120 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6479 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2005 | 429 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2014 | 2637 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 103 | 0.010 |
Why?
|
| Hindlimb | 1 | 2006 | 513 | 0.010 |
Why?
|
| ras-GRF1 | 1 | 2003 | 26 | 0.010 |
Why?
|
| Gene Expression | 2 | 2008 | 7584 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2003 | 102 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 2002 | 4808 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 1320 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2002 | 71 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 4174 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2003 | 316 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 815 | 0.010 |
Why?
|
| Self Tolerance | 1 | 2003 | 123 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2009 | 1891 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4741 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 2510 | 0.010 |
Why?
|
| Motor Skills | 1 | 2006 | 520 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2002 | 103 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2003 | 817 | 0.010 |
Why?
|
| Retrograde Degeneration | 1 | 2002 | 8 | 0.010 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2007 | 556 | 0.010 |
Why?
|
| Axotomy | 1 | 2002 | 71 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2001 | 138 | 0.010 |
Why?
|
| Fibrin | 1 | 2005 | 507 | 0.010 |
Why?
|
| Polycythemia Vera | 1 | 2003 | 161 | 0.010 |
Why?
|
| Keratins | 1 | 2003 | 497 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 660 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 509 | 0.010 |
Why?
|
| Vertebrates | 1 | 2003 | 227 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2007 | 1536 | 0.010 |
Why?
|
| E2F1 Transcription Factor | 1 | 2002 | 178 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2009 | 2208 | 0.010 |
Why?
|
| Acute-Phase Reaction | 1 | 2001 | 91 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3823 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2003 | 410 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2002 | 269 | 0.010 |
Why?
|
| Anxiety | 1 | 2016 | 4572 | 0.010 |
Why?
|
| Genotype | 1 | 2016 | 13009 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 1974 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2003 | 740 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 277 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2225 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 420 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 537 | 0.010 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 1118 | 0.010 |
Why?
|
| Transplantation | 1 | 2002 | 219 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 2218 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 2695 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 256 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2455 | 0.010 |
Why?
|
| Cathepsins | 1 | 2001 | 241 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 1380 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 1263 | 0.010 |
Why?
|
| Epidermis | 1 | 2003 | 527 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 8596 | 0.010 |
Why?
|
| Carotenoids | 1 | 2003 | 621 | 0.010 |
Why?
|
| Fetus | 1 | 2008 | 1864 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 2057 | 0.010 |
Why?
|
| Aging | 2 | 2014 | 8705 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 2002 | 719 | 0.010 |
Why?
|
| Fibrosis | 1 | 2007 | 2048 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2863 | 0.010 |
Why?
|
| Sodium, Dietary | 1 | 2003 | 425 | 0.010 |
Why?
|
| Spironolactone | 1 | 2003 | 412 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2001 | 1157 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2003 | 1165 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 3396 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2002 | 336 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2003 | 790 | 0.010 |
Why?
|
| Rabbits | 1 | 2006 | 4779 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3509 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 1762 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8000 | 0.010 |
Why?
|
| Stem Cells | 1 | 2012 | 3522 | 0.010 |
Why?
|
| Genes | 1 | 2003 | 1844 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2012 | 3600 | 0.010 |
Why?
|
| Matrix Metalloproteinases | 1 | 2001 | 392 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 4234 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 663 | 0.010 |
Why?
|
| Algorithms | 2 | 2014 | 14026 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1202 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 7956 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2007 | 1858 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4287 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2001 | 616 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1249 | 0.010 |
Why?
|
| Neocortex | 1 | 2002 | 417 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 1351 | 0.010 |
Why?
|
| Benzamides | 1 | 2003 | 1370 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6485 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 2917 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2003 | 1358 | 0.010 |
Why?
|
| Cell Death | 1 | 2002 | 1677 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2898 | 0.010 |
Why?
|
| Curriculum | 1 | 2010 | 3741 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 2918 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2003 | 1742 | 0.010 |
Why?
|
| Swine | 1 | 2006 | 5914 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 2902 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 7595 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 2811 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2006 | 2884 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 21341 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 4638 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 5439 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 1886 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2002 | 2667 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3687 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2006 | 2752 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2002 | 3207 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2003 | 3061 | 0.010 |
Why?
|
| Operon | 1 | 1991 | 372 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4354 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2003 | 3049 | 0.010 |
Why?
|
| Genome, Human | 1 | 2003 | 4425 | 0.010 |
Why?
|
| Catalysis | 1 | 1991 | 774 | 0.010 |
Why?
|
| Seizures | 1 | 2003 | 2957 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 2230 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 11902 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1991 | 3395 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1991 | 5789 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1991 | 3846 | 0.000 |
Why?
|